SCHEMBL1089794

SCHEMBL1089794

O=C(NCCNc1nccc(N2CCc3ccccc3C2)n1)C(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM6B O15054 9/20 0.52
▸ GRIN2D O15399 6/20 0.46
▸ GRIN3B O60391 6/20 0.46
▸ GRIN1 Q05586 6/20 0.46
▸ GRIN2A Q12879 6/20 0.46
▸ GRIN2B Q13224 6/20 0.46
▸ GRIN2C Q14957 6/20 0.46
▸ GRIN3A Q8TCU5 6/20 0.46
▸ CHRM1 P11229 1/20 0.46
▸ ADRA1D P25100 1/20 0.46
▸ ADRA1A P35348 1/20 0.46
▸ ADRA1B P35368 1/20 0.46
▸ NFKB1 P19838 1/20 0.45
▸ NR2C2 P49116 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ TAB1 Q15750 1/20 0.45
▸ ADRA2B P18089 1/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090274 0.85 CXCR4 (0.55) ADRA2BADRA2CSLC6A2HRH2HTR1D
SCHEMBL1090037 0.75 L3MBTL1 (0.48) KDM6B
SCHEMBL2954351 0.75 MKNK1 (0.55) KDM6BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2954481 0.73 GRIN2D (0.51) KDM6BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL31681833 0.73 NR2C2 (0.59) KDM6BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2374912 0.73 NR2C2 (0.59) KDM6BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2373974 0.72 GRIN2D (0.60) KDM6BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL31681849 0.72 GRIN2D (0.60) KDM6BGRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL6960891 0.69 ADRA2B (0.48) KDM6BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1264610 0.69 HDAC6 (0.54) KDM6BGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 — — US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 — — US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 — — US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 — — US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 — — US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 KDM6B 2597/4885GRIN2D 3441/4885GRIN3B 1305/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 KDM6B 2597/4885GRIN2D 3441/4885GRIN3B 1305/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 KDM6B 2597/4885GRIN2D 3441/4885GRIN3B 1305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback